IRLAB Receives Positive Feedback from EMA Confirming Alignment with FDA on Phase III ...
GOTHENBURG, SWEDEN / ACCESS Newswire / February 20, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 20 February, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB a company ...
IRLAB Therapeutics: IRLAB Strengthens Its Value Creation Capabilities Through Extended And ...
GOTHENBURG, SWEDEN / ACCESS Newswire / February 17, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)/ IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel trea ...
Le Lézard3 天
IRLAB Strengthens Its Value Creation Capabilities Through Extended And Expanded Debt Financing
GOTHENBURG, SWEDEN / ACCESS Newswire / February 17, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)/ IRLAB Therapeutics AB , a company discovering and developing novel treatments for Parkinson's ...
Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough ...
Multiple system atrophy (MSA) is a rare neurological disorder that leads to the progressive deterioration of nerve cells in ...